Literature DB >> 28213374

Diurnal Differences in Risk of Cardiac Arrhythmias During Spontaneous Hypoglycemia in Young People With Type 1 Diabetes.

Peter Novodvorsky1,2, Alan Bernjak1,3, Elaine Chow2,4, Ahmed Iqbal1,2,4, Lianne Sellors1,2, Scott Williams1,2, Robert A Fawdry1,2, Bhavin Parekh5, Richard M Jacques6, Jefferson L B Marques1, Paul J Sheridan2,4, Simon R Heller7,2.   

Abstract

OBJECTIVE: Hypoglycemia may exert proarrhythmogenic effects on the heart via sympathoadrenal stimulation and hypokalemia. Hypoglycemia-induced cardiac dysrhythmias are linked to the "dead-in-bed syndrome," a rare but devastating condition. We examined the effect of nocturnal and daytime clinical hypoglycemia on electrocardiogram (ECG) in young people with type 1 diabetes. RESEARCH DESIGN AND METHODS: Thirty-seven individuals with type 1 diabetes underwent 96 h of simultaneous ambulatory ECG and blinded continuous interstitial glucose monitoring (CGM) while symptomatic hypoglycemia was recorded. Frequency of arrhythmias, heart rate variability, and cardiac repolarization were measured during hypoglycemia and compared with time-matched euglycemia during night and day.
RESULTS: A total of 2,395 h of simultaneous ECG and CGM recordings were obtained; 159 h were designated hypoglycemia and 1,355 h euglycemia. A median duration of nocturnal hypoglycemia of 60 min (interquartile range 40-135) was longer than daytime hypoglycemia of 44 min (30-70) (P = 0.020). Only 24.1% of nocturnal and 51.0% of daytime episodes were symptomatic. Bradycardia was more frequent during nocturnal hypoglycemia compared with matched euglycemia (incident rate ratio [IRR] 6.44 [95% CI 6.26, 6.63], P < 0.001). During daytime hypoglycemia, bradycardia was less frequent (IRR 0.023 [95% CI 0.002, 0.26], P = 0.002) and atrial ectopics more frequent (IRR 2.29 [95% CI 1.19, 4.39], P = 0.013). Prolonged QTc, T-peak to T-end interval duration, and decreased T-wave symmetry were detected during nocturnal and daytime hypoglycemia.
CONCLUSIONS: Asymptomatic hypoglycemia was common. We identified differences in arrhythmic risk and cardiac repolarization during nocturnal versus daytime hypoglycemia in young adults with type 1 diabetes. Our data provide further evidence that hypoglycemia is proarrhythmogenic.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2017        PMID: 28213374     DOI: 10.2337/dc16-2177

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  30 in total

1.  The Association of Biochemical Hypoglycemia with the Subsequent Risk of a Severe Hypoglycemic Event: Analysis of the DCCT Data Set.

Authors:  Roy W Beck; Richard M Bergenstal; Tonya D Riddlesworth; Craig Kollman
Journal:  Diabetes Technol Ther       Date:  2018-12-21       Impact factor: 6.118

Review 2.  Continuous Glucose Monitoring with Multiple Daily Insulin Treatment: Outcome Studies.

Authors:  Janet B McGill; Andrew Ahmann
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

3.  The Development of New Composite Metrics for the Comprehensive Analytic and Visual Assessment of Hypoglycemia Using the Hypo-Triad.

Authors:  Andreas Thomas; John Shin; Boyi Jiang; Chantal McMahon; Ralf Kolassa; Robert A Vigersky
Journal:  J Diabetes Sci Technol       Date:  2017-07-27

4.  Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.

Authors:  Rayhan A Lal; Laya Ekhlaspour; Korey Hood; Bruce Buckingham
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

5.  Severe Hypoglycemia-Induced Fatal Cardiac Arrhythmias Are Mediated by the Parasympathetic Nervous System in Rats.

Authors:  Candace M Reno; Justin Bayles; Yiqing Huang; Milan Oxspring; Annie M Hirahara; Derek J Dosdall; Simon J Fisher
Journal:  Diabetes       Date:  2019-08-22       Impact factor: 9.461

6.  Continuous Glucose Monitoring in Adults With Type 1 Diabetes With 35 Years Duration From the DCCT/EDIC Study.

Authors:  Rose A Gubitosi-Klug; Barbara H Braffett; Ionut Bebu; Mary L Johnson; Kaleigh Farrell; David Kenny; Victoria R Trapani; Lynne Meadema-Mayer; Elsayed Z Soliman; Rodica Pop-Busui; John M Lachin; Richard M Bergenstal; William V Tamborlane
Journal:  Diabetes Care       Date:  2022-03-01       Impact factor: 19.112

7.  Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.

Authors:  Roy W Beck; Richard M Bergenstal; Tonya D Riddlesworth; Craig Kollman; Zhaomian Li; Adam S Brown; Kelly L Close
Journal:  Diabetes Care       Date:  2018-10-23       Impact factor: 19.112

Review 8.  Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.

Authors:  Rodolfo J Galindo; Roy W Beck; Maria F Scioscia; Guillermo E Umpierrez; Katherine R Tuttle
Journal:  Endocr Rev       Date:  2020-10-01       Impact factor: 19.871

9.  Beyond A1C-Standardization of Continuous Glucose Monitoring Reporting: Why It Is Needed and How It Continues to Evolve.

Authors:  Roy W Beck; Richard M Bergenstal
Journal:  Diabetes Spectr       Date:  2021-05-25

Review 10.  Glucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease.

Authors:  Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Semin Nephrol       Date:  2021-03       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.